CSIMarket
 
Can B Corp   (CANB)
 

Can B's Customers Performance

CANB



 
CANB's Source of Revenues During the corresponding time, Can B Corp saw a revenue deteriorated by -96.36 % year on year, sequentially revenue fell by -94.39 %. While revenue at the Can B Corp 's corporate clients

List of CANB Customers




for the same period Can B Corp revnue deteriorated by -96.36 % year on year, sequentially revenue fell by -94.39 %.

List of CANB Customers

Can B's Business Units






Can B's Comment on Sales, Marketing and Customers



The Company operates in the hemp products and durable medical equipment markets. Its hemp division produces industrial hemp and processes hemp biomass, isolates, and isomers including CBN, CBG, delta-8, and delta-10. Facilities are located in Fort Morgan, Colorado; Mead, Colorado; and Tennessee, with a former facility in Miami, Florida, which closed in late 2022. The Company acquired assets from TWS Pharma, LLC, L7 TWS Pharma, LLC, and Music City Botanicals, LLC. Its hemp products contain 0.3% or less THC (delta-9). The medical device division, comprising Duramed, Inc. and Duramed MI LLC, serves the post-surgery medical patient market, focusing on recovery and pain reduction. Duramed holds exclusive rights to distribute sam® Pro 2.0 and sam® Gel Coupling Patches in the United States for the Personal Injury Protection/No Fault Market under a Memorandum of Understanding with Sam International and ZetrOZ Systems LLC. Customers and related entities include Botanical Biotech, LLC; CO Botanicals LLC; Duramed MI LLC; Duramed, Inc.; L7 TWS Pharma, LLC; Music City Botanicals, LLC; Sam International; TN Botanicals LLC; TWS Pharma, LLC; and ZetrOZ Systems LLC.





Can B’s Comment on Sales, Marketing and Customers


The Company operates in the hemp products and durable medical equipment markets. Its hemp division produces industrial hemp and processes hemp biomass, isolates, and isomers including CBN, CBG, delta-8, and delta-10. Facilities are located in Fort Morgan, Colorado; Mead, Colorado; and Tennessee, with a former facility in Miami, Florida, which closed in late 2022. The Company acquired assets from TWS Pharma, LLC, L7 TWS Pharma, LLC, and Music City Botanicals, LLC. Its hemp products contain 0.3% or less THC (delta-9). The medical device division, comprising Duramed, Inc. and Duramed MI LLC, serves the post-surgery medical patient market, focusing on recovery and pain reduction. Duramed holds exclusive rights to distribute sam® Pro 2.0 and sam® Gel Coupling Patches in the United States for the Personal Injury Protection/No Fault Market under a Memorandum of Understanding with Sam International and ZetrOZ Systems LLC. Customers and related entities include Botanical Biotech, LLC; CO Botanicals LLC; Duramed MI LLC; Duramed, Inc.; L7 TWS Pharma, LLC; Music City Botanicals, LLC; Sam International; TN Botanicals LLC; TWS Pharma, LLC; and ZetrOZ Systems LLC.








CANB's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Can B Corp 1.16 2.04 -2.50 19
SUBTOTAL 0.00 0.00 0.00 -

Sources: Can B Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Can B Corp’s corporate clients.
For your research, we’ve provided 9 tables on Can B Corp corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.